JP2021532171A5 - - Google Patents

Info

Publication number
JP2021532171A5
JP2021532171A5 JP2021522925A JP2021522925A JP2021532171A5 JP 2021532171 A5 JP2021532171 A5 JP 2021532171A5 JP 2021522925 A JP2021522925 A JP 2021522925A JP 2021522925 A JP2021522925 A JP 2021522925A JP 2021532171 A5 JP2021532171 A5 JP 2021532171A5
Authority
JP
Japan
Prior art keywords
glucosamine
cbd
composition according
disease
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021522925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021532171A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/040043 external-priority patent/WO2020009950A1/en
Publication of JP2021532171A publication Critical patent/JP2021532171A/ja
Publication of JP2021532171A5 publication Critical patent/JP2021532171A5/ja
Pending legal-status Critical Current

Links

JP2021522925A 2018-07-02 2019-07-01 カンナビジオールの組み合わせ組成物 Pending JP2021532171A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862692865P 2018-07-02 2018-07-02
US62/692,865 2018-07-02
PCT/US2019/040043 WO2020009950A1 (en) 2018-07-02 2019-07-01 Cannabidiol combination compositions

Publications (2)

Publication Number Publication Date
JP2021532171A JP2021532171A (ja) 2021-11-25
JP2021532171A5 true JP2021532171A5 (cg-RX-API-DMAC7.html) 2022-06-20

Family

ID=69060564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021522925A Pending JP2021532171A (ja) 2018-07-02 2019-07-01 カンナビジオールの組み合わせ組成物

Country Status (8)

Country Link
US (1) US20210275556A1 (cg-RX-API-DMAC7.html)
EP (1) EP3817750A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021532171A (cg-RX-API-DMAC7.html)
CN (1) CN112930183A (cg-RX-API-DMAC7.html)
AU (1) AU2019299213A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020027097A2 (cg-RX-API-DMAC7.html)
CA (1) CA3105082A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020009950A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019165387A1 (en) 2018-02-23 2019-08-29 Spirtos Nicola Michael Cannabis based therapeutic and method of use
IT201900016709A1 (it) * 2019-09-19 2021-03-19 Aqma Italia S P A Composizione antidolorifica e antinfiammatoria ad uso locale
US20210212950A1 (en) * 2020-01-15 2021-07-15 Resurgent Pharmaceuticals, Inc. Orally deliverable formulation to prevent all cause mortality and cardiovascular events
US11364255B2 (en) * 2020-07-01 2022-06-21 Karallief, Inc. Therapeutic herbal compositions for improving joint health
BR102020023664A2 (pt) * 2020-07-02 2022-01-11 Yuzu Llc Composições compreendendo canabidiol e flavononas
CA3185514A1 (en) * 2020-07-17 2022-01-20 Ramachandra MUKUNDA Cannabidiol (cbd) based composition and method for treating pain

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887497B2 (en) * 2002-12-19 2005-05-03 Vitacost.Com, Inc. Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function
GB2414933B (en) * 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
CA2608651A1 (en) * 2005-05-24 2006-11-30 Wellgen, Inc. Compositions and methods for the prevention and treatment of conditions associated with inflammation
JP5204578B2 (ja) * 2007-07-31 2013-06-05 全薬工業株式会社 関節痛改善用組成物、関節痛改善剤、あるいは食品
ES2541485T3 (es) * 2010-10-19 2015-07-21 Parenteral, A.S. Composición para el tratamiento de enfermedades inflamatorias, la cual comprende ácidos boswéllicos y cannabidiol
SG10201402819WA (en) * 2014-06-02 2016-01-28 Beauty Nation Pte Ltd Composition for prevention and treatment of joint pain and the method of preparation thereof
US9486476B2 (en) * 2014-08-05 2016-11-08 Natures Products, Inc Fast acting joint relief formulations
US10398776B1 (en) * 2014-11-03 2019-09-03 Essential Green Goodness LLC Phonophoretic cannabidiol composition and transdermal delivery system
CA2976004C (en) * 2015-02-05 2020-06-02 Colorado Can Llc Purified cbd and cbda, and methods, compositions and products employing cbd or cbda
WO2017203529A1 (en) * 2016-05-24 2017-11-30 Bol Pharma Ltd. Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases
US10542770B2 (en) * 2016-03-18 2020-01-28 Aceso Wellness LLC Cannabinoid emulsion product and process for making the same
US10945967B2 (en) * 2017-05-30 2021-03-16 Jae Wang. Song Formulations of a transdermal patch for pain management
US20190000794A1 (en) * 2017-12-27 2019-01-03 Daniel S. Tanaka Transmucosal cannabinoid formulation including a chitosan excipeint
CA3096842A1 (en) * 2018-04-09 2019-10-17 Ellevet Sciences Hemp extract for treatment of pain in animals
CN110575432B (zh) * 2018-06-08 2021-10-12 汉义生物科技(北京)有限公司 一种含有大麻二酚的组合物及其在动物用品中的应用
WO2020021545A1 (en) * 2018-07-25 2020-01-30 Bol Pharma Ltd. Cannabidiol and glucosamine for treating inflammatory joint diseases

Similar Documents

Publication Publication Date Title
HRP20230272T1 (hr) Postupci za liječenje cistične fibroze
RU2018110647A (ru) Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний
BR112015029918A2 (pt) uso de alta dose de pridopidina para tratar a doença de huntington
JP2017533972A5 (cg-RX-API-DMAC7.html)
HRP20192189T1 (hr) Doziranja i terapijske primjene l-4-klorokinurenina
CL2023000296A1 (es) Uso de dexpramipexol para el tratamiento del asma moderado a grave
CN112930183A (zh) 大麻二酚联合组合物
RU2016137926A (ru) Композиции грапипранта и способы их применения
WO2009003694A3 (en) Method for treating diseases related to mitochondrial dysfunction
CN102920771B (zh) 一种用于治疗家禽球虫病的药物
JP2016505050A5 (cg-RX-API-DMAC7.html)
MX2022012693A (es) Composicion que comprende metilfolato.
KR20120085353A (ko) 가금류, 가축의 조류독감 및 호흡기 질환 치료제 및 예방제
BRPI0715609A2 (pt) Composto, uso de um composto, métodos para produzir um efeito antiproliferativo em um animal de sangue quente, e para tratar uma doença em um animal de sangue quente, e, composição farmacêutica
CN101450069A (zh) 一种用于治疗家禽呼吸道感染的可溶性粉
WO2014106473A1 (zh) 甘草次酸、甘草酸在制备预防或治疗放射性软组织损伤药物中的应用
CN102228466A (zh) 硫酸软骨素氨糖片
CN114788821B (zh) 一种药物组合物及其用途
CN101468025A (zh) 一种用于防治禽大肠杆菌病的可溶性粉
JP6434650B2 (ja) 糖尿病創傷治療用イソキノリン誘導体の新規使用
CN101972325A (zh) 用于治疗鸡球虫病的药物组合物及其制备方法
CN105796543B (zh) U0126在制备治疗帕金森药物上的应用
CN103272068B (zh) 一种含替米考星的中西药复方制剂及其制备方法
CN104906501A (zh) 治疗银屑病的中药组分组合物
EP2606904A1 (de) Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von Gelenkerkrankungen